Torrent Pharma gets green nod for Rs 300 cr project

Updated: Mon, Nov 06, 2017
01:38 pm
PTI
RELATED NEWS
U.S. trade judge recommends sales ban on some Apple iPhones U.S. trade judge recommends sales ban on some Apple iPhones
General Electric in $49 million settlement over Petters fraud General Electric in $49 million settlement over Petters fraud
OxyContin maker Purdue reaches $270 million settlement in Oklahoma opioid case OxyContin maker Purdue reaches $270 million settlement in Oklahoma opioid case
Toyota sees slower sales growth in South America, Caribbean in 2019 - exec Toyota sees slower sales growth in South America, Caribbean in 2019 - exec
Lufthansa plans to buy either Boeing 737 MAX or Airbus A320neo Lufthansa plans to buy either Boeing 737 MAX or Airbus A320neo

The Centre today gave green nod to Torrent Pharmaceuticals' proposal to establish a bulk drug manufacturing unit in Gujarat with an investment of Rs 300 crore, as per an official document.

The Union Environment Ministry issued the environment clearance certificate for the proposed project saying that the approval has been given with certain riders.

The Ahmedabad-based firm's unit will cover 57,737 sq mt area in Kalol taluk. It would have a production capacity of 21,415 tonnes per annum.

The project is estimated to cost about Rs 300 crore and is expected to provide employment to 100 persons, as per the document.

The ministry has asked the company to take necessary permissions from the state pollution control board, ensure zero liquid discharge and take waste minimisation measures.

The company has been asked to plant 25,000 trees per year for next five years. It has also been told to ensure storage of raw materials does not exceed three days at any point of time, it added.

Torrent Pharma has strong presence in cardiovascular, dialectology, pain management, gastro-intestinal segments, dermatology, among other healthcare products.

 

(This article has not been edited by Zeebiz editorial team and is auto-generated from an agency feed.)